The EPA is proposing that 'forever chemicals' be considered hazardous substances
The U.S. EPA’s move to classify nine “forever chemicals” (PFAS) as hazardous substances has triggered debate over how aggressively society should regulate persistent industrial chemicals that accumulate in water, soil, and the human body. Commenters weigh the trade-offs between technological progress and public health, arguing over precautionary (“prove it’s safe”) versus reactive (“prove it’s harmful”) regulation, the adequacy of current toxicity tests, and whether targeting only a handful of PFAS among thousands is meaningful or largely symbolic. Others contrast the U.S. approach with stricter European policies, question the EPA’s effectiveness amid legal and political constraints, and highlight unresolved scientific questions around exposure levels, bioaccumulation, and long‑term endocrine and cancer risks.
Regulation philosophy: “prove safe” vs “prove harmful”
- Contrast between US’ reactive model (“innocent until proven harmful”) and EU’s precautionary, whitelist model for additives.
- Some argue we should invest far more in long-term safety testing and incentives for “safe-by-design” chemistry.
- Others stress that ethical and practical limits mean we can never know “full truth” before use; technology always carries residual risk.
What the EPA proposal covers
- Proposal targets nine specific PFAS as hazardous under RCRA.
- These are already known to be harmful in concentrated form; labs treat them very cautiously.
- Many expect main impact to be on industrial handling, disposal, and liability, not household behavior.
PFAS uses, exposure, and health effects
- Noted uses: firefighting foams (especially at airports, military), textiles, waterproof/outdoor gear, protective clothing, food packaging, and various industrial processes.
- Concern centers on persistence, bioaccumulation, and groundwater contamination; maps and dashboards show widespread but uneven contamination.
- Cited health associations include cholesterol changes, vaccine response changes, liver enzymes, pregnancy complications, lower birth weight, and some cancers.
- Skeptics emphasize that clear harm at typical environmental exposure levels is not yet conclusively shown and ask for stronger evidence on bioaccumulation pathways.
Definitions and “forever chemicals” debate
- Large argument over what counts as PFAS: narrow list vs very broad class of organofluorines.
- Dispute over whether PTFE/Teflon should be treated like other PFAS: some stress its inertness and medical use; others point to PFAS-containing coatings and manufacturing feedstocks.
- “Forever chemicals” is criticized as a vague, alarmist label.
How strict should controls be?
- Views range from “don’t dump chemicals at all” (with critics calling that meaningless without precise definitions) to targeted bans on disposable/low-value uses while allowing critical industrial/medical uses.
- Fear that industry will simply substitute untested analogs (“whack-a-mole”). Suggestions include regulating whole categories and mandating low persistence or non-bioaccumulation.
- Some argue even total, rapid bans can be justified if harms are large enough; others warn of major economic and social disruption.
EPA effectiveness and politics
- Many see listing only 9 of ~12,000 PFAS as toothless; compare to broader EU plans.
- Concerns about regulatory capture and US agencies serving large incumbents.
- Some doubt EPA judgments generally (e.g., CO₂ as “pollutant”), others counter with context-dependent definitions of pollution.